Donor-Recipient ABO Compatibility Independently Influences Survival After Allogeneic HSCT: Outcomes of 281 Patients From a Single Centre

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2015.11.842

Related search